-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
January 01, 2024 - Please be aware that this artifact aligns with the Grade B and the Grade C recommendation in the
USPSTF
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_CDS_Connect_IG_Diabetes_Part_One_Screening_0.pdf
January 01, 2024 - Potential implementers
should be aware that the USPSTF goes on to describe additional populations that
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention_2.pdf
April 01, 2021 - Please be aware that this artifact aligns with the Grade B and the Grade C recommendation in
the USPSTF
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation_Guide_CDS_Connect_Statin_CVD_Clinician_Facing_0.pdf
September 01, 2022 - Please be aware that this artifact aligns with the Grade B and the Grade C recommendation in the
USPSTF
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2023_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
January 01, 2023 - Please be aware that this artifact aligns with the Grade B and the Grade C recommendation in the
USPSTF
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/Implementation%20Guide_Abnormal%20Blood%20Glucose%20and%20Type%202%20DM_Part%20One,%20Screening_Final.pdf
September 01, 2019 - Potential implementers should be aware that the USPSTF
goes on to describe an additional population
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Patient%20Facing%20CDS%20Intervention_Final.pdf
September 01, 2019 - Please be aware that this artifact aligns with the Grade B recommendation in the USPSTF
Statin Use for
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
January 01, 2024 - Please be aware that this artifact aligns with the Grade B recommendation in
the USPSTF Statin Use for
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Patient%20Facing%20CDS%20Intervention_Final_1.pdf
April 01, 2021 - Please be aware that this artifact aligns with the Grade B recommendation in the USPSTF
Statin Use for
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/IG%20Abnormal%20Blood%20Glucose%20Type%202%20DM%20Screening.pdf
September 01, 2021 - Potential implementers should be aware that the USPSTF
goes on to describe an additional population
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/508_2022_CDS_Connect_IG_T2DM_Part_One_Screening_final.pdf
January 01, 2022 - Potential implementers
should be aware that the USPSTF goes on to describe additional populations that
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/Implementation_Guide_Prediabetes_and_Type_2_Diabetes_Part_One_Screening.pdf
September 01, 2022 - Potential implementers
should be aware that the USPSTF goes on to describe additional populations that
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/508_2022_CDS_Connect_IG_Statin_CVD_Patient_Facing_final.pdf
January 01, 2022 - Please be aware that this artifact aligns with the Grade B recommendation in the USPSTF Statin Use
for
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2023_CDS_Connect_IG_T2DM_Part_One_Screening_1.pdf
January 01, 2023 - Potential implementers
should be aware that the USPSTF goes on to describe additional populations that
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
January 01, 2023 - Please be aware that this artifact aligns with the Grade B recommendation in the USPSTF Statin Use
for
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_final.pdf
January 01, 2020 - USPSTF Aspirin Therapy for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer
1
Implementation Guide
USPSTF Aspirin Therapy for the Primary
Prevention of Cardiovascular Disease and
Colorectal Cancer
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ahr…
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
October 01, 2017 - CDS Connect Implementation Guide Draft
Agency for Healthcare Research and Quality (AHRQ)
Agency for Healthcare Research and Quality (AHRQ) Error! No text of specified style in document.
Implementation Guide
Longitudinal ASCVD Risk Assessment Tool for Updated 10-Year ASCVD Risk
Prepared for:
Agency for Healthcare Re…
-
cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
October 01, 2017 - CDS Connect Implementation Guide Draft
Agency for Healthcare Research and Quality (AHRQ)
Agency for Healthcare Research and Quality (AHRQ)
Implementation Guide
Longitudinal ASCVD Risk Assessment Tool for Shared Decision Making
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Hu…
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_USPSTF%20Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_Final.docx
October 01, 2017 - CDS Connect Implementation Guide Draft
Implementation Guide
USPSTF Aspirin Therapy for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
5600 Fishers Lane
Rockville, MD 20857
www.ahrq.gov
Contrac…
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/2024_CDS_Connect_IG_Aspirin_Therapy.pdf
January 01, 2024 - Implementation Guide: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication
Implementation Guide
US Preventive Services Task Force Aspirin Use to Prevent
Cardiovascular Disease: Preventive Medication
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ahrq.gov
…